Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 186,000 shares, an increase of 274.2% from the March 15th total of 49,700 shares. Currently, 1.2% of the company’s stock are short sold. Based on an average trading volume of 7,090,000 shares, the days-to-cover ratio is presently 0.0 days.

Biomerica Price Performance

NASDAQ:BMRA traded down $0.17 during mid-day trading on Wednesday, hitting $0.40. 475,786 shares of the company’s stock were exchanged, compared to its average volume of 2,207,403. Biomerica has a one year low of $0.24 and a one year high of $1.27. The business has a fifty day moving average price of $0.66 and a 200 day moving average price of $0.47. The company has a market cap of $7.39 million, a PE ratio of -1.19 and a beta of 0.37.

Biomerica (NASDAQ:BMRA) last posted its quarterly earnings data on Monday, April 14th. The company reported ($0.06) earnings per share for the quarter. The company had revenue of $1.12 million for the quarter. Biomerica had a negative net margin of 100.52% and a negative return on equity of 90.19%.

Hedge Funds Weigh In On Biomerica

An institutional investor recently raised its position in Biomerica stock. Granahan Investment Management LLC grew its position in Biomerica, Inc. (NASDAQ:BMRA) by 24.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 658,767 shares of the company’s stock after buying an additional 131,306 shares during the period. Granahan Investment Management LLC owned approximately 3.59% of Biomerica worth $198,000 as of its most recent SEC filing. 22.28% of the stock is owned by institutional investors.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.